LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 2.49 | 771.67 | 924 | 867 | 1.0648 | 1.8983 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 4.71 | 771.67 | 879 | 956 | 0.9191 | 0.5229 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 4.71 | 771.67 | 992 | 956 | 1.0373 | 1.2508 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 6.94 | 771.67 | 930 | 1045 | 0.8899 | 0.5318 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 6.94 | 771.67 | 1046 | 1045 | 1.0008 | 1.0038 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 9.16 | 771.67 | 997 | 1138 | 0.8757 | 0.5787 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 9.16 | 771.67 | 1108 | 1138 | 0.9732 | 0.9055 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 11.56 | 771.67 | 1068 | 1280 | 0.8340 | 0.5600 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 11.56 | 771.67 | 1186 | 1280 | 0.9261 | 0.8006 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 13.78 | 771.67 | 1089 | 1459 | 0.7460 | 0.4543 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 13.78 | 771.67 | 1245 | 1459 | 0.8529 | 0.6822 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 16.00 | 771.67 | 1143 | 1585 | 0.7209 | 0.4596 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 16.00 | 771.67 | 1263 | 1585 | 0.7966 | 0.6068 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 18.22 | 771.67 | 1150 | 1741 | 0.6604 | 0.4046 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 18.22 | 771.67 | 1247 | 1741 | 0.7161 | 0.5049 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 20.44 | 771.67 | 1141 | 1910 | 0.5971 | 0.3485 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 20.44 | 771.67 | 1250 | 1910 | 0.6542 | 0.4459 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 22.66 | 771.67 | 1143 | 2141 | 0.5337 | 0.3058 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 22.66 | 771.67 | 1233 | 2141 | 0.5758 | 0.3747 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 24.89 | 771.67 | 1132 | 2397 | 0.4721 | 0.2640 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 24.89 | 771.67 | 1358 | 2397 | 0.5666 | 0.4132 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 27.11 | 771.67 | 1144 | 2675 | 0.4276 | 0.2455 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 27.11 | 771.67 | 1227 | 2675 | 0.4587 | 0.2951 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 29.33 | 771.67 | 1145 | 2939 | 0.3895 | 0.2269 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 29.33 | 771.67 | 1220 | 2939 | 0.4151 | 0.2680 | MN20160304_L01 | K20 |